Literature DB >> 18942075

Tumor suppressor and oncogene actions of TGFbeta1 occur early in skin carcinogenesis and are mediated by Smad3.

Dong-Soon Bae1, Nicholas Blazanin, Mathew Licata, Jessica Lee, Adam B Glick.   

Abstract

Interactions between TGFbeta1 and ras signaling pathways play an important role in cancer development. Here we show that in primary mouse keratinocytes, v-ras(Ha) does not block the early biochemical events of TGFbeta1 signal transduction but does alter global TGFbeta1 mediated gene expression in a gene specific manner. Expression of Smad3 dependent TGFbeta1 early response genes and the TGFbeta1 cytostatic gene expression response were not altered by v-ras(Ha) consistent with an intact TGFbeta1 growth arrest. However, TGFbeta1 and v-ras(Ha) cause significant alteration in genes regulating matrix remodeling as the TGFbeta1 induction of extracellular matrix genes was blocked by v-ras(Ha) but specific matrix proteases associated with cancer progression were elevated. Smad3 deletion in keratinocytes repressed normal differentiation maker expression and caused expression of Keratin 8 a simple epithelial keratin and marker of malignant conversion. Smad3 was required for the TGFbeta1 cytostatic response in v-ras(Ha) keratinocytes, but also for protease induction, keratinocyte attachment and migration. These results show that pro-oncogenic activities of TGFbeta1 can occur early in carcinogenesis before loss of its tumor suppressive function and that selective regulation rather than complete inactivation of Smad3 function may be crucial for tumor progression.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18942075      PMCID: PMC2730634          DOI: 10.1002/mc.20482

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  50 in total

Review 1.  Oncogene activation in chemical carcinogenesis.

Authors:  A Balmain; K Brown
Journal:  Adv Cancer Res       Date:  1988       Impact factor: 6.242

Review 2.  Ski/Sno and TGF-beta signaling.

Authors:  X Liu; Y Sun; R A Weinberg; H F Lodish
Journal:  Cytokine Growth Factor Rev       Date:  2001-03       Impact factor: 7.638

3.  Smads mediate signaling of the TGFbeta superfamily in normal keratinocytes but are lost during skin chemical carcinogenesis.

Authors:  W He; T Cao; D A Smith; T E Myers; X J Wang
Journal:  Oncogene       Date:  2001-01-25       Impact factor: 9.867

4.  Oncogenic ras represses transforming growth factor-beta /Smad signaling by degrading tumor suppressor Smad4.

Authors:  D Saha; P K Datta; R D Beauchamp
Journal:  J Biol Chem       Date:  2001-05-22       Impact factor: 5.157

5.  Genetic programs of epithelial cell plasticity directed by transforming growth factor-beta.

Authors:  J Zavadil; M Bitzer; D Liang; Y C Yang; A Massimi; S Kneitz; E Piek; E P Bottinger
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-05       Impact factor: 11.205

6.  Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response.

Authors:  G S Ashcroft; X Yang; A B Glick; M Weinstein; J L Letterio; D E Mizel; M Anzano; T Greenwell-Wild; S M Wahl; C Deng; A B Roberts
Journal:  Nat Cell Biol       Date:  1999-09       Impact factor: 28.824

7.  Epidermal growth factor signaling via Ras controls the Smad transcriptional co-repressor TGIF.

Authors:  R S Lo; D Wotton; J Massagué
Journal:  EMBO J       Date:  2001-01-15       Impact factor: 11.598

8.  Functional characterization of transforming growth factor beta signaling in Smad2- and Smad3-deficient fibroblasts.

Authors:  E Piek; W J Ju; J Heyer; D Escalante-Alcalde; C L Stewart; M Weinstein; C Deng; R Kucherlapati; E P Bottinger; A B Roberts
Journal:  J Biol Chem       Date:  2001-03-21       Impact factor: 5.157

9.  TGFbeta influences Myc, Miz-1 and Smad to control the CDK inhibitor p15INK4b.

Authors:  J Seoane; C Pouponnot; P Staller; M Schader; M Eilers; J Massagué
Journal:  Nat Cell Biol       Date:  2001-04       Impact factor: 28.824

10.  Inducible expression of transforming growth factor beta1 in papillomas causes rapid metastasis.

Authors:  B H Weeks; W He; K L Olson; X J Wang
Journal:  Cancer Res       Date:  2001-10-15       Impact factor: 12.701

View more
  11 in total

Review 1.  Paradoxical roles of TGF-β signaling in suppressing and promoting squamous cell carcinoma.

Authors:  Fanglong Wu; Kelsey J Weigel; Hongmei Zhou; Xiao-Jing Wang
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2018-01-01       Impact factor: 3.848

2.  TGF-β/β2-spectrin/CTCF-regulated tumor suppression in human stem cell disorder Beckwith-Wiedemann syndrome.

Authors:  Jian Chen; Zhi-Xing Yao; Jiun-Sheng Chen; Young Jin Gi; Nina M Muñoz; Suchin Kundra; H Franklin Herlong; Yun Seong Jeong; Alexei Goltsov; Kazufumi Ohshiro; Nipun A Mistry; Jianping Zhang; Xiaoping Su; Sanaa Choufani; Abhisek Mitra; Shulin Li; Bibhuti Mishra; Jon White; Asif Rashid; Alan Yaoqi Wang; Milind Javle; Marta Davila; Peter Michaely; Rosanna Weksberg; Wayne L Hofstetter; Milton J Finegold; Jerry W Shay; Keigo Machida; Hidekazu Tsukamoto; Lopa Mishra
Journal:  J Clin Invest       Date:  2016-01-19       Impact factor: 14.808

3.  The TGFβ1 pathway is required for NFκB dependent gene expression in mouse keratinocytes.

Authors:  Kelly A Hogan; Anand Ravindran; Michael A Podolsky; Adam B Glick
Journal:  Cytokine       Date:  2013-09-24       Impact factor: 3.861

Review 4.  The crosstalk of RAS with the TGF-β family during carcinoma progression and its implications for targeted cancer therapy.

Authors:  Michael Grusch; Michaela Petz; Thomas Metzner; Deniz Oztürk; Doris Schneller; Wolfgang Mikulits
Journal:  Curr Cancer Drug Targets       Date:  2010-12       Impact factor: 3.428

Review 5.  Two sides of the story? Smad4 loss in pancreatic cancer versus head-and-neck cancer.

Authors:  Stephen P Malkoski; Xiao-Jing Wang
Journal:  FEBS Lett       Date:  2012-02-03       Impact factor: 4.124

6.  TGFβ1 regulates HRas-mediated activation of IRE1α through the PERK-RPAP2 axis in keratinocytes.

Authors:  Saie Mogre; Nicholas Blazanin; Hailey Walsh; Jack Ibinson; Chase Minnich; Chih-Chi Andrew Hu; Adam B Glick
Journal:  Mol Carcinog       Date:  2022-08-17       Impact factor: 5.139

7.  Loss of syndecan-1 is associated with malignant conversion in skin carcinogenesis.

Authors:  Mary Ann Stepp; Sonali Pal-Ghosh; Gauri Tadvalkar; Lamise Rajjoub; Rosalyn A Jurjus; Michael Gerdes; Andrew Ryscavage; Christophe Cataisson; Anjali Shukla; Stuart H Yuspa
Journal:  Mol Carcinog       Date:  2010-04       Impact factor: 4.784

8.  Roles of TGFβ signaling Smads in squamous cell carcinoma.

Authors:  Gangwen Han; Xiao-Jing Wang
Journal:  Cell Biosci       Date:  2011-12-28       Impact factor: 7.133

Review 9.  Overexpression of matrix metalloproteinase-9 in breast cancer cell lines remarkably increases the cell malignancy largely via activation of transforming growth factor beta/SMAD signalling.

Authors:  Haodi Dong; Hongxiu Diao; Ying Zhao; Huihao Xu; Shimin Pei; Jiafeng Gao; Jie Wang; Tariq Hussain; Deming Zhao; Xiangmei Zhou; Degui Lin
Journal:  Cell Prolif       Date:  2019-07-02       Impact factor: 6.831

10.  An H2A histone isotype regulates estrogen receptor target genes by mediating enhancer-promoter-3'-UTR interactions in breast cancer cells.

Authors:  Chia-Hsin Su; Tsai-Yu Tzeng; Ching Cheng; Ming-Ta Hsu
Journal:  Nucleic Acids Res       Date:  2013-12-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.